OTC · Financial Statements
Cellbxhealth PLC (ANPCF) Financial Statements
$0.02
OTC: ANPCF
Market Cap $6.53M
Overview Financials Dividend
Cellbxhealth PLC most recently reported annual revenue of $1.0M, a net loss of $20.0M. Revenue was roughly flat over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $1.0M $1.0M $2.0M $3.0M $1.0M Operating Profit $-17.0M $-24.0M $-22.0M $-15.0M $-20.0M Net Profit $-15.0M $-22.0M $-20.0M $-14.0M $-20.0M EPS $-0.07 $-0.09 $-0.08 $-0.05 $-0.06 Op Margin -1701.4% -2325.4% -995.4% -527.5% -1495.6%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $47.0M $50.0M $31.0M $25.0M $13.0M Total Liabilities $7.0M $10.0M $8.0M $7.0M $5.0M Cash $32.0M $32.0M $16.0M $10.0M $7.0M Borrowings $2.0M $5.0M $5.0M $4.0M $2.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-14.0M $-16.0M $-14.0M $-13.0M $-9.0M Investing Cash Flow $13.0M $-4.0M $-1.0M $0 $0 Financing Cash Flow $0 $0 $0 $0 $-1.0M Net Cash Flow $20.0M $0 $-16.0M $-6.0M $-2.0M Free Cash Flow $-16.0M $-18.0M $-15.0M $-14.0M $-9.0M
Valuation & Return Ratios
Metric Value PEG Ratio — EV / EBITDA — FCF Yield -137.88% Quick Ratio 2.41 Interest Coverage — Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .